As of Aug 28
| +0.55 / +4.51%|
The 9 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 25.83, with a high estimate of 52.00 and a low estimate of 9.16. The median estimate represents a +102.57% increase from the last price of 12.75.
The current consensus among 9 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.